Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients

Journal of Managed Care Pharmacy

Volumn 19, Issue 6, 2013, Pages 468-477

  Desai, Pooja R ^a   Lawson, Kenneth A ^a   Barner, Jamie C ^a   Rascati, Karen L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; DEMOGRAPHY; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HOME CARE; HOSPITALIZATION; HUMAN; ICD-9-CM; INSURANCE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT IDENTIFICATION; PRESCRIPTION; SCHIZOPHRENIA; UNITED STATES;

EID: 84884134360     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2013.19.6.468     Document Type: Article

References (31)

1. Reus VI. Mental disorders. In: Fauci AS, Braunwald E, Kasper D, et al., eds. Harrison's Principles of Internal Medicine. 17th ed. New York: McGraw Hill Companies, Inc.; 2008.
2. Kessler RC, Birnbaum H, Demler O, et al. The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol Psychiatry. 2005;15(8):668-76.
3. Robins LN, Regier DA, eds. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: The Free Press; 1990.
4. Gunderson JG, Mosher LR. The cost of schizophrenia. Am J Psychiatry. 1975;132(9):901-06.
5. Rice DP, Miller LS. The economic burden of schizophrenia: conceptual and methodological issues, and cost estimates. In: Moscarelli M, Rupp A, Sartorius N, eds. Handbook of Mental Health Economics and Health Policy. Vol. 1, Schizophrenia. New York: John Wiley; 1996.
6. Rice DP. The economic impact of schizophrenia. J Clin Psychiatry. 1999;60(Suppl 1):4-6.
7. Wyatt RJ, Henter I, Leary MC, Taylor E. An economic evaluation of schizophrenia-1991. Soc Psychiatry Psychiatr Epidemiol. 1995;30(5):196-205.
8. Wu EQ, Birnbaum HG, Shi L, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry. 2005;66(9):1122-29.
9. McDonald M, Hertz RP, Lustik MB, Unger AN. Healthcare spending for community-dwelling adults with schizophrenia. Am J Manag Care. 2005;11 (8 Suppl):S242-S247.
10. Conwell LJ, Cohen JW. Characteristics of persons with high medical expenditures in the U.S. civilian noninstitutionalized population, 2002. MEPS Statistical Brief #73. March 2005. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://meps.ahrq.gov/data_files/publications/ st73/stat73.pdf. Accessed April 11, 2013.
11. Terkelsen KG, Menikoff A. Measuring the costs of schizophrenia. Implications for a post-institutional era in the U.S. Pharmacoeconomics. 1995;8(3):199-222.
12. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1-10.
13. Lin H-C, Erickson SR, Balkrishnan R. Antidepressant utilization, adherence, and health care spending in the United States: the case of MDD patients 2000-2007. Health Outcomes Res Med. 2011;2(2):e79-89 Available at: http://www.sciencedirect.com/science/article/pii/S1877131911000152. Accessed April 11, 2013.
14. Dixon L, Lyles A, Smith C, et al. Use and costs of ambulatory care services among Medicare enrollees with schizophrenia. Psychiatr Serv. 2001;52(6):786-92.
15. Bartels SJ, Clark RE, Peacock WJ, Dums AR, Pratt SI. Medicare and Medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. Am J Geriatr Psychiatry. 2003;11(6):648-57.
16. Crown WH, Neslusan C, Russo PA, Holzer S, Ozminkowski R, Croghan T. Hospitalization and total medical costs for privately insured persons with schizophrenia. Adm Policy Ment Health. 2001;28(5):335-51.
17. Rascati KL, Johnsrud MT, Crismon ML, Lage MJ, Barber BL. Olanzapine versus risperidone in the treatment of schizophrenia: a comparison of costs among Texas Medicaid recipients. Pharmacoeconomics. 2003;21(10):683-97.
18. Wu EQ, Shi L, Birnbaum H, Hudson T, Kessler R. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychol Med. 2006;36(11):1535-40.
19. Cohen CI, Cohen GD, Blank K, et al. Schizophrenia and older adults. An overview: directions for research policy. Am J Geriatr Psychiatry. 2000;8(1):19-28.
20. Agency for Healthcare Research and Quality (AHRQ). Medical Expenditure Survey Panel (MEPS): survey background. Last revised August 21, 2009. Available at: http://www.meps.ahrq.gov/mepsweb/about_meps/ survey_back.jsp. Accessed April 11, 2013.
21. MEPS-HC Sample design and collection process. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq. gov/survey_comp/hc_data_collection.jsp. Accessed April 11, 2013.
22. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461-94.
23. Glick HA, Doshi JA, Sonnad SS, Polsky D, eds. Economic Evaluation in Clinical Trials. Oxford: Oxford University Press; 2007.
24. Williams R. Marginal effects & discrete change. Margins Part 2. Available at: http://www3.nd.edu/~rwilliam/stats3/Margins02.pdf. Accessed May 24, 2013.
25. Berra S, Borrell C, Rajmil L, et al. Perceived health status and use of healthcare services among children and adolescents. Eur J Public Health. 2006;16(4):405-14.
26. Torrey EF, Bowler A. Geographic distribution of insanity in America: evidence for an urban factor. Schizophr Bull. 1990;16(4):591-604.
27. Marcus SC, Olfson M. Outpatient antipsychotic treatment and inpatient costs of schizophrenia. Schizophr Bull. 2008;34(1):173-80.
28. Zeidler J, Slawik L, Fleischmann J, Greiner W. The costs of schizophrenia and predictors of hospitalization from the statutory health insurance perspective. Health Econ Rev. 2012;2(1):9.
29. Branham A, Moose J, Ferreri S. Retrospective analysis of medication adherence and cost following medication therapy management. Inov Pharm. 2010;1(1):8. Available at: http://www.pharmacy.umn.edu/innovations/prod/ groups/cop/@pub/@cop/@innov/documents/article/cop_article_254656.pdf. Accessed April 11, 2013.
30. Medical Expenditure Panel Survey. MEPS HC-036: 1996-2008 Pooled estimation file. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq.gov/mepsweb/data_stats/download_ data/pufs/h36/h36u08doc.shtml#30Survey. Accessed April 11, 2013.
31. Jacobson G, Neuman T, Damico A. Medicare spending and use of medical services for beneficiaries in nursing homes and other long-term care facilities: a potential for achieving Medicare savings and improving the quality of care. The Henry J. Kaiser Family Foundation. October 2010. Available at: http://www.kff.org/medicare/upload/8109.pdf. Accessed April 11, 2013.